ADDERALL, created in 1998 (Netherlands), from 440 sister brands and 4958 competing brands. ADDERALL is owned by Takeda Pharmaceutical, listed on the stock exchange of Francfort Its International Securities Identification Number (ISIN) is JP3463000004. The sector of ADDERALL is Drug Manufacturers.
Buy Takeda Pharmaceutical share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Other brands
Takeda Pharmaceutical
-
A
-
B
-
C
- COCKPI-T
- COSNOG
- CODELINOV
- CODEFAS
- CODECREG
- CHLORDARBI
- CHLOREDARB
- CLORDARBI
- Chondromimetic
- CARRIERWAVE
- CCH
- CONNEXYN
- Cellerix
- CELLERIX LIVING MEDICINES
- CUATRELLA
- CYTEGRA
- CADESEP
- CAVESEP
- COSULO
- CCI
- CLENDEPIV
- CLENGANT
- CEVELT
- CLENERO
- CIRANDOS
- CYMPETACT
- CEMMIA
- CORIENTA
- CETAND
- COMPETACT
- COMPOZACT
- COACTOL
- CALADAQ
- CLUSIVA
- CELPERIA
- CARBATROL
- CLUDARBI
- COSEPA
- CEDEPSA
- COVRESIS
- CAPACADE
- COVISEP
- CEPISET
- CEPCELIS
- CADERTON
- CHONDROCELECT
- Cupressin
- Cycloform
-
D
-
E
- ERYNDA
- ELDEV
- ELVANSE VOKSEN
- ELVANSE VUXEN
- ELVONTIA
- ELVATURE
- ELVONZA
- ELVANSE ADULT
- EFYZAS
- ELVANTRIN
- ELVANZ
- ELVANS
- ELVANSE
- EDARBYDON
- EDARCLOR
- EDARBYCHLOR
- EDARBYCLOR
- ESPOLIR
- EVALIK
- EXAPAR
- EBNIA
- ENRAPSAR
- ENRAPSO
- ELAPRASE
- ENECLAT
- EVOSS
- EMINAIR
- EQUASYM Methylphenidate Hydrochloride Modified Release Capsules
- EQUIMACT
- EMPRODIS
- EQUASYM
- ESELNA
- EDARBI
- EMJARP
- EcoCAT
- EcCAT
-
F
-
G
-
H
-
I
-
J
-
K
-
L
-
M
-
N
-
O
-
P
-
Q
-
R
-
S
-
T
- takeda-bio-development-center-40000021695-jp3463000004
- Takeda ONCOLOGY
- TOMMORROW
- TYVENSE ADULT
- TAKEDA BETTER HEALTH, BRIGHTER FUTURE
- TYVENSE
- TESILBO
- TAKEDA CHANGING THE FUTURE OF HEALTH
- TROSEPAL
- TROSEPLA
- TUNEPRIO
- TUNECTIVE
- TUNEXUS
- TOBLENT
- TANDEMACT
- TAMITOS
- TACADORM
- TACADEX
- TAKSEN
- TRENANTONE
- TRANSCYTE
- TUGETZUR
- TUZVALD
- TULCABA
- TROZAVEZ
- TASWako
- TRACEPIS
- TORICADE
- TIXANTONE
-
U
-
V
-
W
-
X
-
Z
